Search

Your search keyword '"B Jójárt"' showing total 47 results

Search Constraints

Start Over You searched for: Author "B Jójárt" Remove constraint Author: "B Jójárt"
47 results on '"B Jójárt"'

Search Results

4. P713 Gut microbiota alterations after bowel preparation amongst inflammatory bowel disease patients

5. P721 Faecal microbiota analysis with body composition and nutritional habits simultaneously amongst Crohn’s disease patients

6. P463 Serum and mucosal Serpin E1 concentration correlates with endoscopic activity in inflammatory bowel disease - potential new activity marker

7. P065 Determination of the cytokine pattern of human colon organoids derived from Inflammatory Bowel Disease patients

8. P046 Disease modelling of Inflammatory Bowel Disease by human colon organoids

9. P459 Expression of SerpinE1, a potential new disease activity marker, reflects therapeutic response in Inflammatory Bowel Disease

10. Pathway of the conformational transitions in flexible molecules

11. Shotgun Analysis of Gut Microbiota with Body Composition and Lipid Characteristics in Crohn's Disease.

12. Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases.

13. Orai1 calcium channel inhibition prevents progression of chronic pancreatitis.

14. Human pancreatic ductal organoids with controlled polarity provide a novel ex vivo tool to study epithelial cell physiology.

15. Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls.

16. Tilted State Population of Antimicrobial Peptide PGLa Is Coupled to the Transmembrane Potential.

17. Advances in the optimization of therapeutic drug monitoring using serum, tissue and faecal anti-tumour necrosis factor concentration in patients with inflammatory bowel disease treated with TNF-α antagonists.

18. Allosteric activation of metabotropic glutamate receptor 5.

19. Beyond Chelation: EDTA Tightly Binds Taq DNA Polymerase, MutT and dUTPase and Directly Inhibits dNTPase Activity.

20. Molecular Dynamics and Metadynamics Insights of 1,4-Dioxane-Induced Structural Changes of Biomembrane Models.

21. Oxidatively-mediated in silico epimerization of a highly amyloidogenic segment in the human calcitonin hormone (hCT 15-19 ).

22. Effect of general anesthetics on the properties of lipid membranes of various compositions.

23. Structural features of human DJ-1 in distinct Cys106 oxidative states and their relevance to its loss of function in disease.

24. A Hidden Active Site in the Potential Drug Target Mycobacterium tuberculosis dUTPase Is Accessible through Small Amplitude Protein Conformational Changes.

25. Dynamics and structural determinants of ligand recognition of the 5-HT6 receptor.

26. Glutathione as a prebiotic answer to α-peptide based life.

27. Mixed micelles of sodium cholate and sodium dodecylsulphate 1:1 binary mixture at different temperatures--experimental and theoretical investigations.

28. The effect of oxidative stress on the bursopentin peptide structure: a theoretical study.

29. Molecular ageing: free radical initiated epimerization of thymopentin--a case study.

30. Global optimization of cholic acid aggregates.

31. Identification of Novel Histamine H4 Ligands by Virtual Screening on Molecular Dynamics Ensembles.

32. Penicillin's catalytic mechanism revealed by inelastic neutrons and quantum chemical theory.

33. The impact of molecular dynamics sampling on the performance of virtual screening against GPCRs.

34. Glutathione--hydroxyl radical interaction: a theoretical study on radical recognition process.

36. The effect of a Pro²⁸Thr point mutation on the local structure and stability of human galactokinase enzyme-a theoretical study.

37. β(2)-Adrenergic activity of 6-methoxykaempferol-3-O-glucoside on rat uterus: in vitro and in silico studies.

38. Antioxidant potential of glutathione: a theoretical study.

39. Chemical evolution of biomolecule building blocks. Can thermodynamics explain the accumulation of glycine in the prebiotic ocean?

40. Activation mechanism of the human histamine H4 receptor--an explicit membrane molecular dynamics simulation study.

41. Modeling the human oxytocin receptor for drug discovery efforts.

42. 3D QSAR models for alpha2a-adrenoceptor agonists.

43. Performance of the general amber force field in modeling aqueous POPC membrane bilayers.

44. Receptor-based QSAR studies of non-peptide human oxytocin receptor antagonists.

45. Possible dynamic anchor points in a benzoxazinone derivative-human oxytocin receptor system--a molecular docking and dynamics calculation.

46. Comparative study of eight oxytocin antagonists by simulated annealing.

47. The 3D structure of the binding pocket of the human oxytocin receptor for benzoxazine antagonists, determined by molecular docking, scoring functions and 3D-QSAR methods.

Catalog

Books, media, physical & digital resources